Rybelsus 7 mg – 14 mg

Rybelsus 7 mg – 14 mg | Rybelsus Tablets

Rybelsus is the first oral GLP-1 receptor agonist available in tablet form for the treatment of Type 2 diabetes. It contains the active ingredient Semaglutide, which works by lowering blood sugar levels and improving glucose control. It also contributes to weight loss in some patients.

Indications for Use:

• Treatment of Type 2 diabetes.

• Improves control of blood glucose levels.

• Supports weight loss as an additional effect in some cases.

• Used in conjunction with a healthy diet and exercise, and may be combined with other diabetes medications when needed.

How to Use:

• Initial dose: Rybelsus 7 mg once daily.

• The dose can be increased to Rybelsus 14 mg as directed by your doctor.

• It must be taken on an empty stomach with a small amount of water only. Wait 30 minutes before eating or drinking anything else.

Warnings:

• Not used for the treatment of Type 1 diabetes or diabetic ketoacidosis.

• Use with caution if you have thyroid problems or a family history of thyroid tumors.

• May cause nausea or vomiting, especially at the beginning of treatment.

• Consult your doctor before using it with any other diabetes medications.

Drug Interactions:

• Blood sugar-lowering medications such as insulin or sulfonylureas.

• Some stomach medications or weight loss drugs may require dose adjustments.